AB Inbev
Short position disclosed on September 2, 2026.
0.93% of the capital sold short
1 disclosing funds
1 disclosures on record
BE0974293251 ISIN code
Evolution of the disclosed total
0%0.25%0.5%0.75%1%
Sep 3Sep 4Sep 5Sep 6Sep 7Sep 8
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 0.93% | unchanged | September 2, 2026 |
On the other side: the funds that hold AB Inbev Titelia
Get the moves on AB Inbev by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| September 2, 2026 | Alyeska Investment Group, L.P. | 0.93% | still open |
Download 1 filing as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Belgium
- Solvay 1.39% of the capital sold short
- Biocartis 1.21% of the capital sold short
- Barco 1.02% of the capital sold short
- CP Invest 0.98% of the capital sold short
- EVS 0.89% of the capital sold short
- Syensqo 0.89% of the capital sold short
- D'Ieteren Group 0.79% of the capital sold short
- Azelis 0.71% of the capital sold short
- Umicore 0.70% of the capital sold short
- Lotus Bakeries 0.69% of the capital sold short
- Sequana Medical 0.69% of the capital sold short
- Montea 0.60% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, AB Inbev, source FSMA, data as at September 2, 2026, https://www.quivad.com/action/ab-inbev